2025

Uro-oncology Research UKBristol Conference

20th & 21st November 2025

Watershed

Days

Hours

Mins

Secs

Second annual meeting

Welcome to 2nd meeting of UR-UK

We were delighted to have you with us. This meeting was designed to serve as an incubator for UK uro-oncological research, with the ultimate aim of improving care for patients.

We hope that the collaborative environment and high-level discussions fostered here will strengthen future research plans and advance the management of uro-oncological conditions.

Thursday 20th November

09:30-10:30

Coffee & registration

Location name

10:30-10:40

Introduction

Cinema 3

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Jonathan Aning

B.Med.Sci BMBS DM

Consultant

North Bristol NHS Trust

10:40-11:00

Difficulties in recruiting to surgical clinical trials

Cinema 3

Jonathan Aning

B.Med.Sci BMBS DM

Consultant

North Bristol NHS Trust

11:00-13:00

Breakout sessions one

Prostate

Lower urinary tract symptoms and prostate cancer radiotherapy

Lower urinary tract symptoms and Active Surveillance & PROMS

Lower urinary tract symptoms and radical prostatectomy: is there anything else we need to know?

Bladder

Updates from projects discussed last year

Parastomal hernia post radical cystectomy and ileal conduit formation

Improving care in Female Radical Cystectomy

Renal

Management of localised RCC

SABR, Histotripsy, Ablation, Surveillance

National audit

Cinema 3

13:00-14:00

Lunch

Location name

14:00-16:30

Breakout sessions two

Prostate

RCTs in salvage ablation

PSA follow up in patients without prostate cancer

Bladder

MRI in MIBC pathway

Completeness of TURBT in bladder cancer pathway

Lynch syndrome

Renal

Translational research

Predicting lethality

National prospective audits: IVC thrombectomy; CNx; adjuvant therapy

Cinema 3

16:30-16:50

Listen in on how a CTU works

Location name

Jonathan Aning

B.Med.Sci BMBS DM

Consultant

North Bristol NHS Trust

16:50-17:00

Breakout session roundup

Cinema 3

Jonathan Aning

B.Med.Sci BMBS DM

Consultant

North Bristol NHS Trust

17:00-18:00

Network & Progresssion meetings

Bar area

19:30

Dinner

Muse Brasserie

Thursday 20th November

06:15

5k run with Jonathan Aning

Bristol Harbourside

08:00-10:00

Breakout sessions three

Prostate

Bladder

Non visible haematuria and de-escalation of haematuria pathways - To include biomarkers

De-escalation of bladder cancer pathways. To include biomarkers and reducing surveillance flexible cystoscopies

Pragmatic Quality indicators that might support a National Bladder Cancer Audit

Cinema 3

Renal

Locally advanced disease

Functional imaging

INKCC

10:00-10:15

Coffee

Location name

10:15-12:00

Breakout sessions four

Renal

Bladder

Upper Tract Urothelial Cancer

MMC after URS?

Cinema 3

Flexible session

Open discussion

12:00-12:30

UR-UK Website

Cinema 3

Jonathan Aning

B.Med.Sci BMBS DM

Consultant

North Bristol NHS Trust

12:30-13:30

Lunch

Location name

13:30-15:00

Breakout sessions five

Bladder

Next generation risk stratification in prostate cancer - unlocking the molecular archive

ASPIRE BC

Bladder sparing approaches - Are we ready for this as urologists?

Cinema 3

Flexible session I

Clinical Trials Clinic - Graham MacLennan/Sharon McCann

Jonathan Aning

B.Med.Sci BMBS DM

Consultant

North Bristol NHS Trust

Flexible session II

Rare cancers

15:00-15:30

Conference round up & close

Location name

Jonathan Aning

B.Med.Sci BMBS DM

Consultant

North Bristol NHS Trust

Post-conference

Ut enim ad minim veniam, quis nostrud exercitation ullamco

We hope you’ve enjoyed the intellectually rigorous debates carried out in this friendly and respectful atmosphere.

Our objectives were to make and build on existing relationships that would allow us to create new and ongoing research efforts by improving patient care.

With thanks

Conference partners

Conference sponsors

None sought to influence the agenda of the meeting or those invited to speak at the event.